Markets:

Overview

News

Currencies

International

Treasuries

Sage Therapeutics, Inc. - Common Stock (NQ:SAGE)

8.680 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sage Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

August 29, 2024

From The Schall Law Firm

Via Business Wire

Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

August 04, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Sage Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Pipeline and Business Progress

July 31, 2024

From Sage Therapeutics, Inc.

Via Business Wire

Expert Outlook: Sage Therapeutics Through The Eyes Of 14 Analysts ↗

July 30, 2024

Via Benzinga

Analyst Expectations For Sage Therapeutics's Future ↗

July 12, 2024

Via Benzinga

19 Analysts Have This To Say About Sage Therapeutics ↗

June 20, 2024

Via Benzinga

Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

July 26, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 24, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Sage Therapeutics ↗

May 29, 2024

Via Benzinga

In-Depth Examination Of 9 Analyst Recommendations For Sage Therapeutics ↗

April 18, 2024

Via Benzinga

Sage, Biogen Shelve Development Of Nervous System Disorder Drug After Data Disappoints ↗

July 24, 2024

Sage Therapeutics and Biogen will end further development of SAGE-324 in ET, focusing instead on evaluating future steps.

Via Benzinga

Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails ↗

July 24, 2024

The companies are no longer developing their drug for essential tremor treatment.

Via Investor's Business Daily

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 24, 2024

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!

Via InvestorPlace

Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor

July 24, 2024

From Sage Therapeutics, Inc.

Via Business Wire

Netflix To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Friday ↗

July 19, 2024

Via Benzinga

Sage Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024

July 17, 2024

From Sage Therapeutics, Inc.

Via Business Wire

Delta Air Lines Posts Downbeat Earnings, Joins United Airlines, American Airlines And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

July 11, 2024

Via Benzinga

Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

June 12, 2024

Via Benzinga

Sage Therapeutics Reports Phase 2 Huntington's Data ↗

June 11, 2024

On Tuesday before the market opened, Sage Therapeutics announced findings regarding Huntington's Disease (HD) based upon topline results from the Phase 2 SURVEYOR Study.

Via Benzinga

Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease

June 11, 2024

From Sage Therapeutics

Via Business Wire

Sage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

June 05, 2024

From Sage Therapeutics, Inc.

Via Business Wire

Wall Street's Top 10 Stock Calls This Week - Sunday, June 2 ↗

June 02, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of May 27 through June 2, 2024.

Via Talk Markets

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗

May 21, 2024

Via Benzinga

Sage Therapeutics to Participate in Upcoming May Investor Conferences

May 07, 2024

From Sage Therapeutics

Via Business Wire

SAGE Stock Earnings: Sage Therapeutics Misses EPS, Beats Revenue for Q1 2024 ↗

April 25, 2024

SAGE stock results show that Sage Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress

April 25, 2024

From Sage Therapeutics, Inc.

Via Business Wire

Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday ↗

April 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 24, 2024

Via Benzinga

Netflix, ON Semiconductor And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 19, 2024

Via Benzinga

Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views ↗

April 17, 2024

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded up 0.04% to 37,813.77 while the NASDAQ fell 0.78% to 15,742.21....

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.